UCSF

Desai inducted into International Academy of Medical and Biological Engineering

Tejal Desai, PhD, joined, in September, the 2019 class of fellows of the International Academy of Medical and Biological Engineering (IAMBE) for her in research in microparticle and nanoparticle engineering. IAMBE fellows are “recognized for their outstanding contributions to the profession of medical and biological engineering” through a vote of all academy fellows.

Desai is chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine. She was also recently named the inaugural director of the UCSF Engineering and Applied Sciences Initiative known as Health Innovation Via Engineering (HIVE).

Among her many contributions to research, leadership, and education, Desai recently developed an implantable drug delivery device that spares glaucoma patients from daily medicated eye drops. Nanotechnology from her lab has spurred research into an artificial pancreas, which could provide insulin to diabetic patients without the need for injections.


About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.